Left ventricular longitudinal systolic dysfunction is an independent marker of cardiovascular risk in patients with

Piercarlo Ballo1, Daniele Barone, Arianna Bocelli

  • 1Cardiology Operative Unit, S. Andrea Hospital, La Spezia, Italy. pcballo@tin.it

Insights

Left ventricular longitudinal systolic dysfunction, measured by AVPD and Sm, independently predicts cardiovascular events in hypertension patients. These measures offer higher sensitivity than circumferential indices for risk prediction.

Area of Science:

  • Cardiology
  • Echocardiography
  • Hypertension Research

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Left ventricular (LV) systolic dysfunction is a known complication of hypertension.
  • The prognostic value of longitudinal systolic dysfunction in hypertensive patients requires further investigation.

Purpose of the Study:

  • To evaluate the prognostic significance of LV longitudinal systolic dysfunction in hypertensive individuals.
  • To compare the predictive accuracy of longitudinal systolic indices with conventional circumferential indices.

Main Methods:

  • Assessed LV longitudinal systolic function using M-mode atrioventricular plane displacement (AVPD) and Tissue Doppler-derived mitral annular peak systolic velocity (Sm) in 156 hypertensive patients.
  • Followed patients for major adverse cardiovascular events, including heart failure, myocardial infarction, stroke, and cardiovascular death.
  • Utilized multivariate analysis to determine the independent prognostic value of longitudinal indices.

Main Results:

  • Both AVPD and Sm were significant predictors of cardiovascular events (P < 0.001).
  • Specific cutoffs for AVPD (≤11.4 mm) and Sm (≤8.9 cm/s) identified patients at higher risk.
  • Longitudinal indices demonstrated higher sensitivity but lower specificity compared to circumferential indices for predicting events.
  • The combination of longitudinal and circumferential systolic dysfunction indicated the worst prognosis (P < 0.0001).

Conclusions:

  • LV longitudinal systolic dysfunction serves as an independent marker of cardiovascular risk in hypertensive patients.
  • Longitudinal indices (AVPD, Sm) are more sensitive but less specific than circumferential indices in predicting cardiovascular events.
  • These findings highlight the importance of assessing longitudinal systolic function for comprehensive cardiovascular risk stratification in hypertension.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...